Results 161 to 170 of about 11,363 (224)
Exploration of metformin-based drug combination for mitigating diabetes-associated atherosclerotic diseases. [PDF]
World J DiabetesQu B, Li Z, Hu W.
europepmc +1 more source
Food Minor Bioactive Compounds of Polyphenolic and Polyprenolic Nature Are Promising Agents for the Prevention and Therapy of Non-Alcoholic Fatty Liver Disease. [PDF]
MoleculesBalakina A +3 more
europepmc +1 more source
Fenofibrate and Diabetic Retinopathy. [PDF]
Diabetes TherParra-Pineda A +7 more
europepmc +1 more source
[Hypolipidemic activity of phenolic acids from <i>Inula japonica</i> Thunb.] [PDF]
Nan Fang Yi Ke Da Xue Xue BaoChen Y +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Perspectives of the non-statin hypolipidemic agents
Pharmacology & Therapeutics, 2010This review focuses on the non-statin strategies for the treatment of hyperlipidemias in humans. Even if statins remain the major hypolipidemic drugs at present, an increasing number of patients that are treated with statins raises as well the numbers of patients suffering from side effects or not responding well to the therapy.
Damjana Rozman, Katalin Monostory
exaly +3 more sources
Adipokines and Lipoproteins: Modulation by Antihyperglycemic and Hypolipidemic Agents
Metabolic Syndrome and Related Disorders, 2014 Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines.
Rizvi A. A. +5 more
openaire +4 more sources